These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 19142131
21. Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study. Chidlow G, Casson R, Sobrado-Calvo P, Vidal-Sanz M, Osborne NN. Mol Vis; 2005 Jun 02; 11():387-96. PubMed ID: 15947739 [Abstract] [Full Text] [Related]
22. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Hernández M, Urcola JH, Vecino E. Exp Eye Res; 2008 May 02; 86(5):798-806. PubMed ID: 18394603 [Abstract] [Full Text] [Related]
23. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. Ben Simon GJ, Bakalash S, Aloni E, Rosner M. Am J Ophthalmol; 2006 Jun 02; 141(6):1105-11. PubMed ID: 16765680 [Abstract] [Full Text] [Related]
24. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC, Waxman SG. Invest Ophthalmol Vis Sci; 2005 Nov 02; 46(11):4164-9. PubMed ID: 16249495 [Abstract] [Full Text] [Related]
25. Y-P30 confers neuroprotection after optic nerve crush in adult rats. Macharadze T, Landgraf P, Pape HC, Wahle P, Kreutz MR. Neuroreport; 2011 Aug 03; 22(11):544-7. PubMed ID: 21666514 [Abstract] [Full Text] [Related]
26. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Chen H, Weber AJ. Invest Ophthalmol Vis Sci; 2001 Apr 03; 42(5):966-74. PubMed ID: 11274073 [Abstract] [Full Text] [Related]
27. BDNF preserves the dendritic morphology of alpha and beta ganglion cells in the cat retina after optic nerve injury. Weber AJ, Harman CD. Invest Ophthalmol Vis Sci; 2008 Jun 03; 49(6):2456-63. PubMed ID: 18263808 [Abstract] [Full Text] [Related]
28. The effects of FK506 on retinal ganglion cells after optic nerve crush. Freeman EE, Grosskreutz CL. Invest Ophthalmol Vis Sci; 2000 Apr 03; 41(5):1111-5. PubMed ID: 10752948 [Abstract] [Full Text] [Related]
29. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Martin KR, Levkovitch-Verbin H, Valenta D, Baumrind L, Pease ME, Quigley HA. Invest Ophthalmol Vis Sci; 2002 Jul 03; 43(7):2236-43. PubMed ID: 12091422 [Abstract] [Full Text] [Related]
30. Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury. Nakatani M, Shinohara Y, Takii M, Mori H, Asai N, Nishimura S, Furukawa-Hibi Y, Miyamoto Y, Nitta A. Exp Eye Res; 2011 Dec 03; 93(6):873-9. PubMed ID: 22001716 [Abstract] [Full Text] [Related]
31. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI. Ophthalmic Res; 2007 Dec 03; 39(2):69-75. PubMed ID: 17284931 [Abstract] [Full Text] [Related]
32. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat. Maeda K, Sawada A, Matsubara M, Nakai Y, Hara A, Yamamoto T. Invest Ophthalmol Vis Sci; 2004 Mar 03; 45(3):851-6. PubMed ID: 14985301 [Abstract] [Full Text] [Related]
33. Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy. Peng PH, Chiou LF, Chao HM, Lin S, Chen CF, Liu JH, Ko ML. Exp Eye Res; 2010 Apr 03; 90(4):528-34. PubMed ID: 20114044 [Abstract] [Full Text] [Related]
34. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME. Invest Ophthalmol Vis Sci; 2001 Apr 03; 42(5):975-82. PubMed ID: 11274074 [Abstract] [Full Text] [Related]
35. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine. Fitzgerald M, Payne SC, Bartlett CA, Evill L, Harvey AR, Dunlop SA. Invest Ophthalmol Vis Sci; 2009 Nov 03; 50(11):5456-62. PubMed ID: 19474405 [Abstract] [Full Text] [Related]
36. [Neuroprotection and regeneration after traumatic lesion of the optic nerve]. Heiduschka P, Fischer D, Thanos S. Klin Monbl Augenheilkd; 2004 Aug 03; 221(8):684-701. PubMed ID: 15343454 [Abstract] [Full Text] [Related]
37. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma. Levkovitch-Verbin H, Quigley HA, Martin KR, Harizman N, Valenta DF, Pease ME, Melamed S. Exp Eye Res; 2005 May 03; 80(5):663-70. PubMed ID: 15862173 [Abstract] [Full Text] [Related]
38. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF. Invest Ophthalmol Vis Sci; 2003 Aug 03; 44(8):3388-93. PubMed ID: 12882786 [Abstract] [Full Text] [Related]
39. Neuroprotective effect of nipradilol, an NO donor, on hypoxic-ischemic brain injury of neonatal rats. Kakizawa H, Matsui F, Tokita Y, Hirano K, Ida M, Nakanishi K, Watanabe M, Sato Y, Okumura A, Kojima S, Oohira A. Early Hum Dev; 2007 Aug 03; 83(8):535-40. PubMed ID: 17157452 [Abstract] [Full Text] [Related]
40. Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A. Exp Eye Res; 2009 Mar 03; 88(3):535-41. PubMed ID: 19084521 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]